Boehringer

Showing 15 posts of 150 posts found.

Boehringer targets AML

March 1, 2013
Research and Development, Sales and Marketing AML, Boehringer

Boehringer Ingelheim is to begin a pivotal trial of its investigative treatment volasertib in patients with acute myeloid leukaemia (AML). …

J&J image

J&J seeks end to Doxil shortage as Ben Venue signs consent decree

January 28, 2013
Manufacturing and Production Ben Venue, Boehringer, Caelyx, Doxil, J&J, JJ, Janssen

Johnson & Johnson says it has taken steps to establish new supplies of its cancer drug Doxil/Caelyx, which remains in …

Boehringer in oncology tie-up

January 16, 2013
Research and Development, Sales and Marketing Boehringer, Cancer, horizon, x-man

Boehringer Ingelheim has entered a five-year tie-up with a UK biotech company which specialises in helping research into personalised medicines. …

Boehringer hands back Lilly drug

January 8, 2013
Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly

Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …

Boehringer to make cancer antibody for Apexigen

December 11, 2012
Manufacturing and Production, Sales and Marketing APX005, Apexigen, Boehringer

Boehringer Ingelheim has won a contract from US biotech company Apexigen to manufacture APX005, an antibody-based drug candidate for various …

Trajenta may reduce stroke damage

December 4, 2012
Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …

Pharma manufacturing news in brief

November 20, 2012
Manufacturing and Production Alfa Laval, Boehringer, Fujifilm, Health Canada, Novartis

Our latest round-up of manufacturing news includes a facility contract for Alfa Laval, plus updates from Fujifilm, Novartis, Boehringer Ingelheim …

lilly image

New plant positions Lilly for changing insulin market

November 6, 2012
Manufacturing and Production Boehringer, insulin, lilly

Eli Lilly has unveiled plans for a $140 million expansion of its insulin plant in Indianapolis as it starts to …

Social media image

Digital Pharma: what should we talk about?

October 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Pfizer, digital pharma, social media, twiiter

The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …

Boehringer closing Petersburg API plant

September 25, 2012
Manufacturing and Production API, Boehringer, Petersburg, chemicals

Boehringer Ingelheim has decided to close down one of its active pharmaceutical ingredient (API) manufacturing facilities in the US because …

Boehringer submits new lung cancer drug

September 20, 2012
Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib

Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …

Boehringer image

Boehringer says it is rolling out ‘fully disposable’ biomanufacturing

September 18, 2012
Manufacturing and Production Boehringer, CMO, GMP, SUSs

Boehringer Ingelheim says it has developed a production platform for biopharmaceuticals that makes full use disposable technologies both upstream and …

Syrum game

Boehringer beta launches Syrum on Facebook

September 17, 2012
Medical Communications, Sales and Marketing Boehringer, Facebook, Syrum

Boehringer Ingelheim has announced the beta launch of its first social game on Facebook, the eagerly-awaited Syrum. Other sectors have …

Online programme to help diabetes patients

September 14, 2012
Medical Communications, Sales and Marketing Boehringer, diabetes, lilly

Boehringer Ingelheim and Eli Lilly have launched an online initiative which they say will help diabetes sufferers make simple lifestyle …

Boehringer signs diabetes research deal

September 7, 2012
Sales and Marketing Boehringer, diabetes, obesity

Boehringer Ingelheim has signed a four-year research agreement with a top Swiss university to look at the underlying causes of …

The Gateway to Local Adoption Series

Latest content